Company intelligence / Profile preview

Control Delivery Systems

Watertown, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Developed and commercialized implantable drug delivery devices for sustained release of pharmaceuticals. The company's core technology enabled long-term controlled release of drugs for ophthalmic and other indications. After acquisition by pSivida, the platform contributed to FDA-approved products such as ILUVIEN for diabetic macular edema.

Therapeutic areas: OphthalmologyOther
Modalities: DevicePolymer-drug conjugate therapyHydrogel-based drug delivery therapy
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Control Delivery Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Control Delivery Systems.

Explore the full profile